We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Současná farmakoterapie benigní hyperplazie prostaty dle doporučení EAU.
- Authors
Horák, Aleš
- Abstract
Pharmacological treatment is the basis for conservative treatment of lower urinary tract symptoms (LUTS) in benign prostatic hyperplasia (BPH). Currently, pharmacological treatment is based on a1-blockers, 5a-reductase inhibitors, muscarinic receptor antagonists, phosphodiesterase 5 inhibitors, beta-3 adrenoceptor agonists and a combination of some of them. In indicated cases, phytopharmaceuticals, most commonly containing Serenoa repens, may be used in patients with minor LUTS.
- Publication
Urologie Pro Praxi, 2021, Vol 22, Issue 3, p125
- ISSN
1213-1768
- Publication type
Article
- DOI
10.36290/uro.2021.017